FindTrial
Sign In

Calculation of salivary hepcidin levels in oral cancer .

Salivary Liver Expressed Antimicrobial Peptide- 1(LEAP-1) as an early predictor for oral squamous cell carcinoma(OSCC) in tobacco chewers of North Bangalore.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/048259
Enrollment
44
Registered
2022-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Rajiv Gandhi University of Health Sciences
Lead Sponsor
Sri Rajiv Gandhi College of Dental Sciences and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Male and female patients with different grades of Oral squamous cell carcinoma

Exclusion criteria

Exclusion criteria: Patients who are systemically ill with chronic inflammatory diseases and patients who have laready been treated for Oral squamous cell carcinoma and are on treatment

Design outcomes

Primary

MeasureTime frame
Hepcidin levels in saliva with varying degrees of Oral squamous cell carcinomaTimepoint: At baseline that is at the start of the study—

Secondary

MeasureTime frame
varying levels of hepcidin in different stage Oral squamous cell carcinomaTimepoint: At the end of 3 months—

Countries

India

Contacts

Public ContactDr Bhavana T Veerabasavaiah

Sri Rajiv Gandhi College of Dental Sciences and Hospital

bhavanatv@gmail.com9901894529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026